The Journal of Urology
Volume 181, Issue 5 , Pages 2009-2017, May 2009

The Necessity of Adrenalectomy at the Time of Radical Nephrectomy: A Systematic Review

  • Rebecca L. O'Malley

      Affiliations

    • Nothing to disclose.
  • ,
  • Guilherme Godoy

      Affiliations

    • Supported by the Bruce and Cynthia Sherman Fellowship in Urologic Oncology.
  • ,
  • Jamie A. Kanofsky

      Affiliations

    • Nothing to disclose.
  • ,
  • Samir S. Taneja

      Affiliations

    • Corresponding Author InformationCorrespondence: Division of Urologic Oncology, Department of Urology, NYU Cancer Institute, New York University Langone Medical Center, 150 East 32nd St., Suite 200, New York, New York 10016 (telephone: 646-825-6321; FAX: 646-825-6399)
    • Financial interest and/or other relationship with GTX, Envisioneering Medical, Watson Pharmaceuticals, Ipsen, U.S. HIFU, Fujirebo and GlaxoSmithKline.

Urologic Oncology Program, Department of Urology, New York University School of Medicine, New York, New York

Received 13 August 2008 published online 16 March 2009.

Purpose

We describe the literature base pertaining to adrenalectomy at radical nephrectomy and present a pragmatic approach based on primary tumor and disease characteristics.

Materials and Methods

Literature searches were performed via the National Center for Biotechnology Information databases using various keywords. Articles that pertained to the concomitant use of adrenalectomy with radical nephrectomy were surveyed.

Results

The incidence of solitary, synchronous, ipsilateral adrenal involvement, ie that which is potentially curable with ipsilateral adrenalectomy along with nephrectomy, is much lower than previously thought at 1% to 5%. Evidence to date supports increased size and T stage, multifocality, upper pole location and venous thrombosis as risk factors for adrenal involvement. Cross-sectional imaging is now accurate at demonstrating the absence of adrenal involvement but still carries a significant risk of false-positives. The morbidity of adrenalectomy is minimal except in those patients with metachronous contralateral adrenal metastasis in whom the impact of adrenal insufficiency can be devastating. Disease specific and overall survival of those undergoing radical nephrectomy, with or without adrenalectomy, are similar. The survival of patients with widespread metastatic disease is historically poor regardless of whether adrenalectomy is performed. There is evidence for a survival advantage in patients with isolated adrenal metastasis, although this group comprises no more than 2% of those undergoing surgery for renal tumors.

Conclusions

The apparent benefit of ipsilateral adrenalectomy does not support it as a standard practice in all patients with normal imaging. However, it should be considered in select cases in which there are risk factors for adrenal involvement.

Key Words: adrenalectomy, adrenal gland neoplasms, nephrectomy, carcinoma, renal cell, kidney neoplasms

Abbreviations and Acronyms: CT, computerized tomography, MRI, magnetic resonance imaging, NPV, negative predictive value, PPV, positive predictive value, RCC, renal cell carcinoma, RNx, radical nephrectomy, SSIAI, solitary synchronous ipsilateral adrenal involvement

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Editor's Note: This article is the first of 5 published in this issue for which category 1 CME credits can be earned. Instructions for obtaining credits are given with the questions on pages 2392 and 2393.

PII: S0022-5347(09)00040-8

doi:10.1016/j.juro.2009.01.018

The Journal of Urology
Volume 181, Issue 5 , Pages 2009-2017, May 2009